Page 117 - TD-4-3

Tumor Discovery BrECADD-induced ileus and GI hemorrhage

information/adcetris-epar-product-information_en.pdf doi: 10.1016/j.surge.2024.09.009
[Last accessed on 2025 Jun 08].
15. Lee KJ, Kim HM, Jung JW, et al. Gastrointestinal hemorrhage
11. Gao S, Zhang M, Wu K, et al. Risk of adverse events in after concurrent chemoradiotherapy in locally advanced
lymphoma patients treated with brentuximab vedotin: pancreatic cancer. Gut Liver. 2013;7(1):106-111.
A systematic review and meta-analysis. Expert Opin Drug
Saf. 2020;19(5):617-623. doi: 10.5009/gnl.2013.7.1.106
doi: 10.1080/14740338.2020.1718103 16. Ferdinandus J, Kaul H, Fosså A, et al. PET-guided brecadd
in older patients with advanced-stage classic hodgkin
12. Shi Y, Yao K, Zhao J, Yue Y, Wu H. Gastrointestinal toxicity of lymphoma: Results of the phase 2 part of the GHSG HD21
antibody-drug conjugates: A pharmacovigilance study using trial. Blood. 2024;144 Suppl 1:568–568.
the FAERS database. BMC Pharmacol Toxicol. 2025;26:50.
17. Connors JM, Jurczak W, Straus DJ, et al. Brentuximab
doi: 10.1186/s40360-025-00877-4 vedotin with chemotherapy for stage III or IV hodgkin’s
13. O’Brien JW, Rogers M, Gallagher M, Rockall T. Management lymphoma. N Engl J Med. 2018;378(4):331-344.
of massive gastrointestinal haemorrhage. Surgery (Oxford). doi: 10.1056/NEJMoa1708984
2022;40(9):582-592.
18. Herrera AF, LeBlanc M, Castellino SM, et al.
14. Hall T, Temperley HC, Mac Curtain BM, et al. Transcatheter Nivolumab+AVD in advanced-stage classic hodgkin’s
arterial embolisation (TAE) to treat acute upper gastrointestinal
bleeding secondary to gastric cancer: A systematic review and lymphoma. N Engl J Med. 2024;391(15):1379-1389.
meta-analysis. Surgeon. 2024;22(6):e213-e220. doi: 10.1056/NEJMoa2405888

Volume 4 Issue 3 (2025) 109 doi: 10.36922/TD025180033